ATE198746T1 - Pyrimidinderivate und pharmazeutische zusammensetzungen - Google Patents

Pyrimidinderivate und pharmazeutische zusammensetzungen

Info

Publication number
ATE198746T1
ATE198746T1 AT95108380T AT95108380T ATE198746T1 AT E198746 T1 ATE198746 T1 AT E198746T1 AT 95108380 T AT95108380 T AT 95108380T AT 95108380 T AT95108380 T AT 95108380T AT E198746 T1 ATE198746 T1 AT E198746T1
Authority
AT
Austria
Prior art keywords
carbon atoms
integer
alkyl
nhc
nhr
Prior art date
Application number
AT95108380T
Other languages
English (en)
Inventor
Mikiro Yanaka
Fuyuhiko Nishijima
Hiroyuki Enari
Michihito Ise
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Application granted granted Critical
Publication of ATE198746T1 publication Critical patent/ATE198746T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT95108380T 1994-06-01 1995-06-01 Pyrimidinderivate und pharmazeutische zusammensetzungen ATE198746T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14227494 1994-06-01

Publications (1)

Publication Number Publication Date
ATE198746T1 true ATE198746T1 (de) 2001-02-15

Family

ID=15311548

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95108380T ATE198746T1 (de) 1994-06-01 1995-06-01 Pyrimidinderivate und pharmazeutische zusammensetzungen

Country Status (6)

Country Link
US (1) US5585381A (de)
EP (1) EP0686631B1 (de)
AT (1) ATE198746T1 (de)
AU (1) AU679361B2 (de)
CA (1) CA2150609C (de)
DE (1) DE69519895T2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
BR0313059B8 (pt) 2002-07-29 2021-07-27 Rigel Pharmaceuticals composto, e, composição farmacêutica
RS53109B (en) 2003-07-30 2014-06-30 Rigel Pharmaceuticals Inc. 2,4 PIRIMIDINDIAMINE COMPOUNDS FOR USE IN TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES
ATE540035T1 (de) * 2004-11-24 2012-01-15 Rigel Pharmaceuticals Inc Spiro-2,4-pyrimidindiamin-verbindungen und ihre verwendungen
US20060270694A1 (en) * 2005-05-03 2006-11-30 Rigel Pharmaceuticals, Inc. JAK kinase inhibitors and their uses
US9284301B2 (en) 2010-03-25 2016-03-15 Merck Sharp & Dohme Corp. Soluble guanylate cyclase activators
ES2564503T3 (es) 2010-05-27 2016-03-23 Merck Sharp & Dohme Corp. Activadores de la guanilato-ciclasa soluble

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748177A (en) * 1984-03-26 1988-05-31 Warner-Lambert Company Guanine derivatives
ZA875052B (en) 1986-07-11 1989-03-29 Du Pont Angiotensin ii receptor blocking imidazoles
US5138069A (en) 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5071867A (en) 1990-02-28 1991-12-10 Vanderbilt University Treatment of chronic kidney disease with angiotensin I converting enzyme inhibitor
DE69129611T2 (de) * 1990-08-20 1998-12-17 Eisai Co., Ltd., Tokio/Tokyo Sulfonamid-Derivate
IE912956A1 (en) 1990-09-10 1992-03-11 Abbott Lab Angiotensin ii receptor antagonists
JPH05320143A (ja) * 1992-03-18 1993-12-03 Mochida Pharmaceut Co Ltd 新規ピリミジン誘導体

Also Published As

Publication number Publication date
DE69519895D1 (de) 2001-02-22
EP0686631B1 (de) 2001-01-17
US5585381A (en) 1996-12-17
AU2042795A (en) 1996-01-04
DE69519895T2 (de) 2001-06-13
EP0686631A1 (de) 1995-12-13
AU679361B2 (en) 1997-06-26
CA2150609A1 (en) 1995-12-02
CA2150609C (en) 1998-12-08

Similar Documents

Publication Publication Date Title
SE8802173D0 (sv) Pyrimidine derivatives
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
ES2082780T3 (es) Derivados de acido bisfosfonico heterociclicos.
FI98729B (fi) Menetelmä farmaseuttisesti vaikuttavan puriinijohdannaisen valmistamiseksi
PT992509E (pt) Novos derivados macrolidos
ATE198746T1 (de) Pyrimidinderivate und pharmazeutische zusammensetzungen
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
ES2068413T3 (es) Derivados de 4-fenilftalazina.
DK0420121T3 (da) Antitumormiddel
NO890440D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
ES2096572T3 (es) Nuevos derivados de glucosidos de antraciclina y procedimiento para su preparacion.
NO173057C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzanilidderivater
NO985202L (no) Anti-heliobacter pylori-preparater inneholdende 1-metylcarbapenemderivater
DK0420224T3 (da) Anthihepatopatisk middel
ES2070154T3 (es) Derivados de piridoindol y procedimientos para su preparacion.
PT855398E (pt) Derivados sasquiterpeno tendo actividade antiviral
DK168284A (da) Troponderivater
DK1264836T3 (da) Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater
DK0952157T3 (da) 9a, 11b-dehydroderivater af 9-oxim-3-keto-6-0-methylerythromycin
GR3030952T3 (en) Salmycins, a process for their preparation and their use as a pharmaceutical.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties